Dilantin Infatabs Tablet, Chewable
Product Images NDC 0071-0007
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dilantin Infatabs (NDC 0071-0007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Parke-davis Div Of Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Dilantin 02)
Logo (Dilantin 03)
Principal Display Panel (50 mg Tablet Bottle Label)
This is a medication called Dilantin Infatabs, which contains 50mg of phenytoin. It is recommended for pediatric patients and should be taken in divided doses of 5mg/g daily. Patients are advised to refer to the package insert for full prescribing information. Dilantin Infatabs should not be taken once a day and should be kept in a tight container in a room at controlled room temperature, protected from moisture. The medication can be chewed or swallowed. It is distributed by Parke-Davis, a division of Pfizer Inc. Accompanying medication guide should always be dispensed along with the medication.*
Principal Display Panel (50 mg Tablet Blister Pack)
Principal Display Panel (50 mg Tablet Blister Pack Box)
This appears to be a product label for Dilantin® Phenytoin Chewable Tablets, USP, a medication used to treat certain types of seizures. The label emphasizes the importance of dispensing the medication along with the accompanying medication guide, provides dosing instructions, and includes information about the packaging size and manufacturer.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.